Chilamakuri R, Agarwal S. COVID-19: characteristics and therapeutics. Cells. 2021;10(2):206.
Article CAS PubMed PubMed Central Google Scholar
Fernandes Q, Inchakalody VP, Merhi M, Mestiri S, Taib N, Moustafa Abo El-Ella D, et al. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Ann Med. 2022;54(1):524–40.
Article CAS PubMed PubMed Central Google Scholar
Putra HP, Arimaswati AHS, Karya ID. Analysis of risk factors for death in COVID-19 patients at Bahteramas Regional General Hospital, Southeast Sulawesi Province. Hypertension. 24(28):2.
Triggle CR, Bansal D, Ding H, Islam MM, Farag EABA, Hadi HA, Sultan AA. A comprehensive review of viral characteristics, transmission, pathophysiology, immune response, and management of SARS-CoV-2 and COVID-19 as a basis for controlling the pandemic. Front Immunol. 2021;12:631139.
Article CAS PubMed PubMed Central Google Scholar
Rodrigues R, Costa de Oliveira S. The impact of angiotensin-converting enzyme 2 (ACE2) expression levels in patients with comorbidities on COVID-19 severity: a comprehensive review. Microorganisms. 2021;9(8):1692.
Article CAS PubMed PubMed Central Google Scholar
Jalaleddine N, Bouzid A, Hachim M, Sharif-Askari NS, Mahboub B, Senok A, et al. ACE2 polymorphisms impact COVID-19 severity in obese patients. Sci Rep. 2022;12(1):21491.
Article CAS PubMed PubMed Central Google Scholar
Bakhshandeh B, Sorboni SG, Javanmard A-R, Mottaghi SS, Mehrabi M-r, Sorouri F, et al. Variants in ACE2; potential influences on virus infection and COVID-19 severity. Infect Genet Evol. 2021;90:104773.
Article CAS PubMed PubMed Central Google Scholar
Alsharif W, Qurashi A. Effectiveness of COVID-19 diagnosis and management tools: a review. Radiography. 2021;27(2):682–7.
Article CAS PubMed Google Scholar
Mi S, Zhang J, Zhang W, Huang RS. Circulating microRNAs as biomarkers for inflammatory diseases. Microrna. 2013;2(1):64–72.
Article CAS PubMed Central Google Scholar
Maranini B, Ciancio G, Ferracin M, Cultrera R, Negrini M, Sabbioni S, Govoni M. microRNAs and inflammatory immune response in SARS-CoV-2 infection: a narrative review. Life. 2022;12(2):288.
Article CAS PubMed PubMed Central Google Scholar
Wang Y, Li J, Zhang L, Sun H-X, Zhang Z, Xu J, et al. Plasma cell-free RNA characteristics in COVID-19 patients. Genome Res. 2022;32(2):228–41.
Article PubMed PubMed Central Google Scholar
Vishnubalaji R, Shaath H, Alajez NM. Protein coding and long noncoding RNA (lncRNA) transcriptional landscape in SARS-CoV-2 infected bronchial epithelial cells highlight a role for interferon and inflammatory response. Genes. 2020;11(7):760.
Article CAS PubMed PubMed Central Google Scholar
Jalaleddine N, Gaudet M, Mogas A, Hachim M, Senok A, Sharif-Askari NS, et al. Cell free ACE2 RNA: a potential biomarker of COVID-19 severity. Respir Med. 2023;219:107409.
Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA localization and function. J Cell Biol. 2021;220(2):e202009045.
Article CAS PubMed PubMed Central Google Scholar
Xing C, Sun S-g, Yue Z-Q, Bai F. Role of lncRNA LUCAT1 in cancer. Biomed Pharmacother. 2021;134:111158.
Article CAS PubMed Google Scholar
Statello L, Guo C-J, Chen L-L, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96–118.
Article CAS PubMed Google Scholar
Wang W, Yang N, Wen R, Liu C-F, Zhang T-N. Long noncoding RNA: regulatory mechanisms and therapeutic potential in sepsis. Front Cell Infect Microbiol. 2021;11:563126.
Article CAS PubMed PubMed Central Google Scholar
Wu Y, Zhao T, Deng R, Xia X, Li B, Wang X. A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood. Sci Rep. 2021;11(1):7991.
Article CAS PubMed PubMed Central Google Scholar
Wang L, Xuan Z, Zhou S, Kuang L, Pei T. A novel model for predicting LncRNA-disease associations based on the LncRNA-MiRNA-disease interactive network. Curr Bioinform. 2019;14(3):269–78.
Sefatjoo Z, Mohebbi SR, Hosseini SM, Shoraka S, Niasar MS, Baghaei K, et al. Evaluation of long non-coding RNAs EGOT, NRAV, NRIR and mRNAs ISG15 and IFITM3 expressions in COVID-19 patients. Cytokine. 2024;175:156495.
Article CAS PubMed Google Scholar
Tayel SI, El-Masry EA, Abdelaal GA, Shehab-Eldeen S, Essa A, Muharram NM. Interplay of LncRNAs NEAT1 and TUG1 in incidence of cytokine storm in appraisal of COVID-19 infection. Int J Biol Sci. 2022;18(13):4901.
Article CAS PubMed PubMed Central Google Scholar
Guo C, Qi Y, Qu J, Gai L, Shi Y, Yuan C. Pathophysiological functions of the lncRNA TUG1. Curr Pharm Design. 2020;26(6):688–700.
Xue M, Xia F, Wang Y, Zhu L, Li Y, Jia D, et al. The role of LncRNA TUG1 in obesity-related diseases. Mini Rev Med Chem. 2022;22(9):1305–13.
Article CAS PubMed Google Scholar
Lv J, Kong Y, Gao Z, Liu Y, Zhu P, Yu Z. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma. Int J Biochem Cell Biol. 2018;101:19–28.
Article CAS PubMed Google Scholar
Tang W, Shen Z, Guo J, Sun S. Screening of long non-coding RNA and TUG1 inhibits proliferation with TGF-β induction in patients with COPD. Int J Chronic Obstr Pulm Dis. 2016:2951–64.
Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011;10(1):1–17.
Bitarafan S, Yari M, Broumand MA, Ghaderian SMH, Rahimi M, Mirfakhraie R, et al. Association of increased levels of lncRNA H19 in PBMCs with risk of coronary artery disease. Cell J (Yakhteh). 2019;20(4):564.
Yao Y, Xiong G, Jiang X, Song T. The overexpression of lncRNA H19 as a diagnostic marker for coronary artery disease. Revista Da Associação Médica Brasileira. 2019;65:110–7.
Pope C, Mishra S, Russell J, Zhou Q, Zhong X-B. Targeting H19, an imprinted long non-coding RNA, in hepatic functions and liver diseases. Diseases. 2017;5(1):11.
Article PubMed PubMed Central Google Scholar
Wang B, Suen CW, Ma H, Wang Y, Kong L, Qin D, et al. The roles of H19 in regulating inflammation and aging. Front Immunol. 2020;11:579687.
Article CAS PubMed PubMed Central Google Scholar
Yang Z, Zhang T, Han S, Kusumanchi P, Huda N, Jiang Y, Liangpunsakul S. Long noncoding RNA H19–a new player in the pathogenesis of liver diseases. Translational Res. 2021;230:139–50.
Chen M-J, Deng J, Chen C, Hu W, Yuan Y-C, Xia Z-K. LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis. Int J Biochem Cell Biol. 2019;113:27–36.
留言 (0)